Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Wastewater Surveillance: A Game-Changer for Public Health in India
- 2 2025 SCO Summit: A Call for Global Balance and Reform
- 3 Radioactive Pollution in Punjab: Groundwater at Risk
- 4 AI in Courts: Efficiency Tool or Risk to Judicial Reasoning?
- 5 Water Management & Conservation: The Role of Modern Technology
- 6 Biochar: Scalable Solution for Durable Carbon Removal
- 7 Trade Tensions Rise: Indian Exports Face 50% US Tariff
- 8 Harnessing AI for Climate Action: India’s Path to Global Leadership
- 9 India Achieves 20% Ethanol Blending Target: Milestone on the Path to Sustainability
- 10 Toxic Trails: Growing Menace of Heavy Metal Pollution in India